Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Pierre A. MORGON is CEO of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement. He is also Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, of Alma Biotherapeutics and of Vaccitech. Pierre has over 30 years of experience in the global life science industry, especially with vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level and as CEO of start-ups. He is a lecturer in several MBA programs in world-class business schools and in life science conferences. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD and IMD.
Immunology, Vaccine, Oncology, Murine Virology, Antiviral Chemotherapy, Effects of inhibitors on viral replication, Studies on the role of herpesviruses in cancer, Tumor immunology, Pathology of AIDS